Alpha Cognition (FRA:7N70) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7N70 Alpha Cognition Inc FRA:7N70
22 GF Score
Price €6.70
! 3 Warning Signs
View Full Analysis

What is Alpha Cognition Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:7N70 vs HURA, MENS, ENLV: Short Interest Comparison

For the Biotechnology subindustry, Alpha Cognition's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alpha Cognition Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Cognition's Short Interest distribution charts can be found below:

* The bar in red indicates where Alpha Cognition's Short Interest falls into.


FRA:7N70
22GF Score
Alpha Cognition Inc FRA:7N70
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha Cognition Business Description

Other Exchanges ACOG:USA
Address 1200 - 750 West Pender Street, Vancouver, BC, CAN, V6C 2T8
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
22GF Score

Get the complete analysis for FRA:7N70

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.70
Price